Literature DB >> 9703168

Factors affecting the age of onset and rate of progression of Alzheimer's disease.

J V Bowler1, D G Munoz, H Merskey, V Hachinski.   

Abstract

OBJECTIVES: To assess the role of cerebrovascular disease, sex, education, occupation, year of birth, leukoaraiosis, congophilic angiopathy, family history, and other demographic factors on the reported age of onset and rate of progression of Alzheimer's disease.
METHODS: Analysis of data from the University of Western Ontario Dementia Study, a prospective longitudinal study of dementia patients with clinical and 6 monthly psychometric follow up to postmortem based in a university memory disorders clinic with secondary and tertiary referrals. There were 172 patients with dementia. The main outcome measures were the reported age of onset of cognitive decline as described by the family (available in 168) and rate of progression as measured during the linear phase of the extended scale for dementia, which could be calculated in 66. The cases subdivided into 49 cases of definite Alzheimer's disease without infarcts, 25 cases of otherwise definite Alzheimer's disease with infarcts, 79 cases of probable Alzheimer's disease without infarcts, and 19 such cases with infarcts.
RESULTS: The age of onset was not influenced by the rate of progression, the presence of cerebral infarcts, or congophilic angiopathy. Educational level, occupational level, sex, family history, year of birth, reported age of onset, severity at entry, an ischaemic score, and the presence of leukoariosis, affected neither age of onset nor the rate of progression. An earlier year of birth had a major effect and higher education had a minor effect on earlier age of onset. The earlier the year of birth, the lower the educational level and the greater the accrual of cerebral infarcts.
CONCLUSIONS: Contrary to series without pathological verification, age of onset in this study was not affected by occupation. Education had a modest effect on earlier reported onset, probably reflecting earlier recognition. As birth year has a strong effect on educational level and the occurrence of cerebral infarcts, this must be taken into account when analysing for risk factors for Alzheimer's disease.

Entities:  

Mesh:

Year:  1998        PMID: 9703168      PMCID: PMC2170212          DOI: 10.1136/jnnp.65.2.184

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  61 in total

1.  Leuko-araiosis.

Authors:  V C Hachinski; P Potter; H Merskey
Journal:  Arch Neurol       Date:  1987-01

2.  The clinical diagnosis of Alzheimer's disease.

Authors:  J P Wade; T R Mirsen; V C Hachinski; M Fisman; C Lau; H Merskey
Journal:  Arch Neurol       Date:  1987-01

3.  Use of the Mini-Mental State Examination (MMSE) in a community population of mixed ethnicity. Cultural and linguistic artifacts.

Authors:  J I Escobar; A Burnam; M Karno; A Forsythe; J Landsverk; J M Golding
Journal:  J Nerv Ment Dis       Date:  1986-10       Impact factor: 2.254

4.  Prevalence of severe dementia in Finland.

Authors:  R Sulkava; J Wikström; A Aromaa; R Raitasalo; V Lehtinen; K Lahtela; J Palo
Journal:  Neurology       Date:  1985-07       Impact factor: 9.910

5.  Development and application of the extended scale for dementia.

Authors:  E L Hersch
Journal:  J Am Geriatr Soc       Date:  1979-08       Impact factor: 5.562

6.  Age at onset and rate of progression of Alzheimer's disease.

Authors:  F J Huff; J H Growdon; S Corkin; T J Rosen
Journal:  J Am Geriatr Soc       Date:  1987-01       Impact factor: 5.562

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Sensitivity and specificity of the extended scale for dementia.

Authors:  C Lau; K Wands; H Merskey; M Boniferro; L Carriere; H Fox; V C Hachinski
Journal:  Arch Neurol       Date:  1988-08

10.  Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment.

Authors:  L Berg; J P Miller; M Storandt; J Duchek; J C Morris; E H Rubin; W J Burke; L A Coben
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

View more
  12 in total

1.  Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study.

Authors:  Maria C Norton; Kathleen W Piercy; Peter V Rabins; Robert C Green; John C S Breitner; Truls Ostbye; Christopher Corcoran; Kathleen A Welsh-Bohmer; Constantine G Lyketsos; Joann T Tschanz
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-06-29       Impact factor: 4.077

2.  Data requirements in a model of the natural history of Alzheimer's disease.

Authors:  T J Chaussalet; W A Thompson
Journal:  Health Care Manag Sci       Date:  2001-02

3.  The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset.

Authors:  Joann T Tschanz; Maria C Norton; Peter P Zandi; Constantine G Lyketsos
Journal:  Int Rev Psychiatry       Date:  2013-12

4.  The effect of education on rCBF changes in Alzheimer's disease: a longitudinal SPECT study.

Authors:  Haruo Hanyu; Tomohiko Sato; Soichiro Shimizu; Hidekazu Kanetaka; Toshihiko Iwamoto; Kiyoshi Koizumi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-12       Impact factor: 9.236

5.  Education and rates of cognitive decline in incident Alzheimer's disease.

Authors:  N Scarmeas; S M Albert; J J Manly; Y Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

6.  Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer's disease.

Authors:  Melisa Gumus; Namita Multani; Michael L Mack; Maria Carmela Tartaglia
Journal:  Geroscience       Date:  2021-01-09       Impact factor: 7.581

7.  Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years.

Authors:  Martin R Farlow; Mary L Lilly
Journal:  BMC Geriatr       Date:  2005-01-19       Impact factor: 3.921

8.  Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health care case register in london.

Authors:  Gayan Perera; Mizanur Khondoker; Matthew Broadbent; Gerome Breen; Robert Stewart
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

9.  A common brain network links development, aging, and vulnerability to disease.

Authors:  Gwenaëlle Douaud; Adrian R Groves; Christian K Tamnes; Lars Tjelta Westlye; Eugene P Duff; Andreas Engvig; Kristine B Walhovd; Anthony James; Achim Gass; Andreas U Monsch; Paul M Matthews; Anders M Fjell; Stephen M Smith; Heidi Johansen-Berg
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

10.  Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia.

Authors:  Robert S Wilson; Tianhao Wang; Lei Yu; Francine Grodstein; David A Bennett; Patricia A Boyle
Journal:  Neurology       Date:  2021-07-14       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.